tiprankstipranks
Q32 Bio (DE:DB0)
FRANKFURT:DB0
Germany Market
DB0
Q32 Bio
RESEARCH TOOLSreports

Q32 Bio (DB0) Income Statement

2 Followers

Q32 Bio Income Statement

Last quarter (Q2 2026), Q32 Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Q32 Bio's net income was $-8.95M. See Q32 Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 53.74M$ 0.00$ -6.65M$ 6.65M$ 0.00
Gross Profit
$ 53.74M$ 0.00$ -6.65M$ 6.65M$ 0.00
Operating Expenses
$ 36.84M$ 66.10M$ 41.60M$ 45.88M$ 36.69M
Depreciation and Amortization
$ 391.00K$ 487.00K$ 499.00K$ 370.00K$ 47.00K
EBITDA
$ 31.31M$ -44.50M$ -47.76M$ -38.85M$ -36.65M
Operating Income
$ 16.90M$ -66.10M$ -48.26M$ -39.23M$ -36.69M
Other Income/Expenses
$ 12.92M$ 18.39M$ -5.17M$ -3.52M$ -324.00K
Pretax Income
$ 29.82M$ -47.71M$ -53.42M$ -42.75M$ -37.02M
Net Income
$ 29.82M$ -47.73M$ -53.74M$ -42.81M$ -37.56M
Per Share Metrics
Basic EPS
$ 2.42$ -5.12$ -4.51$ -3.59$ -3.15
Diluted EPS
$ 2.42$ -6.58$ -4.51$ -3.59$ -3.15
Weighted Average Shares Outstanding
 12.30M 9.32M 11.93M 11.93M 11.93M
Weighted Average Shares Outstanding (Diluted)
 12.31M 9.66M 11.93M 11.93M 11.93M
Currency in USD

Q32 Bio Earnings and Revenue History